Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy

References

• Globocan. Cancer Today. 2018. Available from: https://gco.iarc.fr/today/home
   Google Scholar
• Hamilton W, Lancashire R, Sharp D, et al. The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study. BMC Med. 2009;7:17.
   PubMed Web of Science ®Google Scholar
• Adelstein BA, Macaskill P, Chan SF, et al. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterol. 2011;11:65.
   PubMed Web of Science ®Google Scholar
• Brenner DR, Ruan Y, Shaw E, et al. Increasing colorectal cancer incidence trends among younger adults in Canada. Prev Med. 2017;105:345–349.
   PubMed Web of Science ®Google Scholar
• Godber IM, Todd LM, Fraser CG, et al. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms. Clin Chem Lab Med. 2016;54:595–602.
   PubMed Web of Science ®Google Scholar
• McDonald PJ, Digby J, Innes C, et al. Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis. 2013;15:e151–e159.
   PubMed Web of Science ®Google Scholar
• Mowat C, Digby J, Strachan JA, et al. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms. Gut. 2016;65:1463–1469.
   PubMed Web of Science ®Google Scholar
• Widlak MM, Thomas CL, Thomas MG, et al. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients. Aliment Pharmacol Ther. 2017;45:354–363.
   PubMed Web of Science ®Google Scholar
• Fraser CG, Rapi S, Rubeca T. RE: A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin. J Natl Cancer Inst. 2015;108:djv312.
   PubMedGoogle Scholar
• Fraser CG, Allison JE, Young GP, et al. Improving the reporting of evaluations of faecal immunochemical tests for haemoglobin: the FITTER standard and checklist. Eur J Cancer Prev. 2015;24:24–26.
   PubMed Web of Science ®Google Scholar
• Schisterman EF, Perkins NJ, Liu A, et al. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology. 2005;16:73–81.
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329:168–169.
   PubMed Web of Science ®Google Scholar
• Laanani M, Coste J, Blotiere PO, et al. Patient, procedure, and endoscopist risk factors for perforation, bleeding, and splenic injury after colonoscopies. Clin Gastroenterol Hepatol. 2019;17:719–727.e13.
   PubMed Web of Science ®Google Scholar
• Westwood M, Corro Ramos I, Lang S, et al. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2017;21:1–234.
   PubMed Web of Science ®Google Scholar
• Turvill J, Mellen S, Jeffery L, et al. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer. Scand J Gastroenterol. 2018;53:1526–1534.
   PubMed Web of Science ®Google Scholar
• Boroff ES, Disbrow M, Crowell MD, et al. Adenoma and polyp detection rates in colonoscopy according to indication. Gastroenterol Res Pract. 2017;2017:7207595.
   PubMedGoogle Scholar
• Rex DK, Ponugoti PL. Calculating the adenoma detection rate in screening colonoscopies only: is it necessary? Can it be gamed? Endoscopy. 2017;49:1069–1074.
   PubMed Web of Science ®Google Scholar
• Yang PF, Wong SW. Adenoma detection rate in colonoscopy: is indication a predictor? Surg Laparosc Endosc Percutan Tech. 2016;26:156–161.
   PubMed Web of Science ®Google Scholar
• Hogberg C, Karling P, Rutegard J, et al. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: the usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study. Scand J Gastroenterol. 2017;52:69–75.
   PubMed Web of Science ®Google Scholar
• Lee DW, Koo JS, Choe JW, et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol. 2017;23:6474–6481.
   PubMed Web of Science ®Google Scholar
• Gillberg A, Ericsson E, Granstrom F, et al. A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer. Colorectal Dis. 2012;14:e539–46.
   PubMed Web of Science ®Google Scholar
• Hogberg C, Karling P, Rutegard J, et al. Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer. Scand J Prim Health Care. 2013;31:209–214.
   PubMed Web of Science ®Google Scholar
• Wilkens J, Thulesius H, Schmidt I, et al. The 2015 National Cancer Program in Sweden: Introducing standardized care pathways in a decentralized system. Health Policy. 2016;120:1378–1382.
   PubMed Web of Science ®Google Scholar
• Cubiella J, Salve M, Diaz-Ondina M, et al. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria. Colorectal Dis. 2014;16:O273–282.
   PubMed Web of Science ®Google Scholar
• Digby J, Steele RJ, Strachan JA, et al. Do other variables add value to assessment of the risk of colorectal disease using faecal immunochemical tests for haemoglobin? Ann Clin Biochem. 2019;56:472–479.
   PubMed Web of Science ®Google Scholar
• Herrero JM, Vega P, Salve M, et al. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study. BMC Gastroenterol. 2018;18:155.
   PubMed Web of Science ®Google Scholar
• Quyn AJ, Steele RJ, Digby J, et al. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: not FIT for purpose? Ann Clin Biochem. 2018;55:69–76.
   PubMed Web of Science ®Google Scholar
• Adams LA, Pawlik J, Forbes GM. Nonattendance at outpatient endoscopy. Endoscopy. 2004;36:402–404.
   PubMed Web of Science ®Google Scholar
• Chopra D, Hookey LC. Comorbid illness, bowel preparation, and logistical constraints are key reasons for outpatient colonoscopy nonattendance. Can J Gastroenterol Hepatol. 2016;2016:1–6.
   Google Scholar
• Shafer LA, Walker JR, Waldman C, et al. Factors associated with anxiety about colonoscopy: the preparation, the procedure, and the anticipated findings. Dig Dis Sci. 2018;63:610–618.
   PubMed Web of Science ®Google Scholar
• Mowat C, Digby J, Strachan JA, et al. Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study. BMJ Open Gastroenterol. 2019;6:e000293.
   PubMed Web of Science ®Google Scholar